The Anglo-Swedish pharmaceutical giant said Tuesday that for the second quarter, core earnings per share rose to $2.17 from $1.98 in the same period a year prior. Revenue increased to $14.46 billion ...

The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13% ...

FTSE 100 Live Tuesday Barclays profit tops forecastsAstraZeneca backs 2025 guidanceGreggs hit by cost headwinds ...

The FTSE 100 has started higher, up 13 points to 9,094 in a mixed early trading for European markets. Games Workshop Group ...

(Alliance News) - AstraZeneca PLC on Tuesday reported better-than-expected second quarter revenue, and raised its dividend, boosted by strong sales from its cancer portfolio.

The FTSE 100 index opened up 11.70 points, 0.1%, at 9,093.14. The FTSE 250 was down marginally by 0.82 points at 21,950.74, and the AIM All-Share was down 2.61 points, 0.3%, at 770.41.